Your Source for Venture Capital and Private Equity Financings

Select An Article

DraftKings Closes $41M Round
2014-08-25
BOSTON, MA, DraftKings, Inc., today announced that it has closed a $41 million Series C round of funding led by The Raine Group.
Read More
Dynamic Signal Raises $12M
2014-08-25
SAN FRANCISCO, CA, Dynamic Signal, industry leader in employee advocacy solutions, announced that it has closed a $12M million Series C financing round.
Read More
GlobeIn Lands $1M
2014-08-25
MOUNTAIN VIEW, CA, GlobeIn has announced that it has raised $1 million in additional funding from backers Deepak Chopra and former IBM executive Doug Maine.
Read More
Aldea Pharmaceuticals Pulls In $24M
2014-08-25
REDWOOD CITY, CA, Aldea Pharmaceuticals, a company pioneering novel therapeutics to treat aldehyde metabolism disorders, today announced that it has closed a $24 million Series B equity financing.
Read More
Swift Navigation Closes $2.6M Seed Round
2014-08-25
SAN FRANCISCO, CA, Swift Navigation, a San Francisco-based startup building centimeter-accurate GPS technology, announced today that it has raised a $2.6 million seed round.
Read More
Advanced Cooling Therapy Receives $1.5M
2014-08-25
CHICAGO, IL, Medical device firm Advanced Cooling Therapy (ACT) has closed a $1.5 million Series A financing round.
Read More
Appcelerator Secures $22M Financing Round
2014-08-25
MOUNTAIN VIEW, CA, Appcelerator, provider of the leading enterprise mobile engagement platform, today announced a $22 million round of Series D funding.
Read More
Medalogix Raises $5M
2014-08-25
NASHVILLE, TN, Medalogix has received a $5 million investment from Connecticut-based Coliseum Capital Management.
Read More
ViaCyte Receives $20M
2014-08-25
SAN DIEGO, CA, ViaCyte, Inc., a privately held regenerative medicine company announced today that it has entered into a Rights Agreement with Janssen Research & Development LLC.
Read More
EMRes Technologies Closes $2.9M Series A Fund
2014-08-25
AUSTIN, TX, EMRes Technologies Inc. reports receiving $2.9 million Series A round of funding.
Read More
Vaccinogen Lands $80M
2014-08-25
FREDERICK, MD, Vaccinogen, Inc., a cancer immunotherapy development company, announced today the initial closing of a private placement of $80 million of units and common stock.
Read More